Matches in DBpedia 2016-04 for { ?s ?p "A Leprostatic agent is a drug that interferes with proliferation of the bacterium that causes leprosy.The following agents are leprostatic agents: acedapsone clofazimine dapsone desoxyfructo-serotonin diucifon ethionamide rifampicin rifapentine sulfameter thalidomideLeprosy is a chronic infectious disease caused by Mycobacterium leprae. Host defenses are crucial in determining the patient’s response to the disease, the clinical presentation, and the bacillary load. These factors also influence the length of therapy and the risk of adverse reactions to medication.M. leprae cannot be grown on routine laboratory culture media, so drug sensitivity testing in vitro is not possible. Growth and drug susceptibility testing are done by injecting into animal models. One description of a clinical picture that results from tuberculoid leprosy is characterized by intact cell-mediated immunity, a positive lepromin skin reaction, granuloma formation, and a relative paucity of bacilli.At the other extreme, lepromatous leprosy is characterized by depressed cell-mediated immunity, numerous bacilli within the tissues, no granulomas, and a negative skin test for lepromin. Within these two extremes are the patients with an intermediate or borderline form of leprosy who show a variable lepromin reaction and few bacilli; they may progress to either tuberculoid or lepromatousleprosy."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Leprostatic_agent abstract "A Leprostatic agent is a drug that interferes with proliferation of the bacterium that causes leprosy.The following agents are leprostatic agents: acedapsone clofazimine dapsone desoxyfructo-serotonin diucifon ethionamide rifampicin rifapentine sulfameter thalidomideLeprosy is a chronic infectious disease caused by Mycobacterium leprae. Host defenses are crucial in determining the patient’s response to the disease, the clinical presentation, and the bacillary load. These factors also influence the length of therapy and the risk of adverse reactions to medication.M. leprae cannot be grown on routine laboratory culture media, so drug sensitivity testing in vitro is not possible. Growth and drug susceptibility testing are done by injecting into animal models. One description of a clinical picture that results from tuberculoid leprosy is characterized by intact cell-mediated immunity, a positive lepromin skin reaction, granuloma formation, and a relative paucity of bacilli.At the other extreme, lepromatous leprosy is characterized by depressed cell-mediated immunity, numerous bacilli within the tissues, no granulomas, and a negative skin test for lepromin. Within these two extremes are the patients with an intermediate or borderline form of leprosy who show a variable lepromin reaction and few bacilli; they may progress to either tuberculoid or lepromatousleprosy.".
- Q6527835 abstract "A Leprostatic agent is a drug that interferes with proliferation of the bacterium that causes leprosy.The following agents are leprostatic agents: acedapsone clofazimine dapsone desoxyfructo-serotonin diucifon ethionamide rifampicin rifapentine sulfameter thalidomideLeprosy is a chronic infectious disease caused by Mycobacterium leprae. Host defenses are crucial in determining the patient’s response to the disease, the clinical presentation, and the bacillary load. These factors also influence the length of therapy and the risk of adverse reactions to medication.M. leprae cannot be grown on routine laboratory culture media, so drug sensitivity testing in vitro is not possible. Growth and drug susceptibility testing are done by injecting into animal models. One description of a clinical picture that results from tuberculoid leprosy is characterized by intact cell-mediated immunity, a positive lepromin skin reaction, granuloma formation, and a relative paucity of bacilli.At the other extreme, lepromatous leprosy is characterized by depressed cell-mediated immunity, numerous bacilli within the tissues, no granulomas, and a negative skin test for lepromin. Within these two extremes are the patients with an intermediate or borderline form of leprosy who show a variable lepromin reaction and few bacilli; they may progress to either tuberculoid or lepromatousleprosy.".